Researchers are using an advanced brain imaging method called MEG to understand why Parkinson’s drug levodopa doesn’t work ...

Simon Fraser University researchers are using a new approach to brain imaging that could improve how drugs are prescribed to ...

A drug used for Parkinson's disease has been shown to be effective in reducing the symptoms of difficult to treat depression, ...

A cough medicine used for decades in Europe called Ambroxol has shown promise for treating dementia in people with ...

A cough medicine used for decades in Europe called Ambroxol has shown promise for treating dementia in people with ...

Understand Parkinson's disease, its symptoms, and the crucial role of clinical trials in treatment and research, especially for Black Americans.

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.

Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...

Parkinson’s disease is primarily distinguished by resting tremors, bradykinesia, muscle rigidity, and balance issues, all of which have a substantial influence on patients' quality of life. Although ...

The earlier Parkinson's disease is spotted, the better – for patients, their loved ones, and scientists working toward ...

Parkinson's Disease: Researchers at Simon Fraser University reveal how brain imaging techniques can explain the inconsistent effects of levodopa in Parkinson's patients, potentially leading to ...

A landmark study by London researchers investigating the use of a cough medicine called Ambroxo to slow the progression of ...